爱沙尼亚 - 爱沙尼亚文 - Ravimiamet

lex ano uab - tsetirisiin - õhukese polümeerikattega tablett - 10mg 30tk

爱沙尼亚 - 爱沙尼亚文 - Ravimiamet

olainfarm as - abirateroon - õhukese polümeerikattega tablett - 500mg 56tk; 500mg 60tk

爱沙尼亚 - 爱沙尼亚文 - Ravimiamet

olainfarm as - abirateroon - tablett - 250mg 120tk

欧盟 - 爱沙尼亚文 - EMA (European Medicines Agency)

novartis europharm limited  - gozetotide - radionukliidi pildistamine - diagnostilised radiofarmatseutilised ühendid - see ravim on mõeldud ainult diagnostiliseks kasutamiseks. locametz, after radiolabelling with gallium 68, is indicated for the detection of prostate specific membrane antigen (psma) positive lesions with positron emission tomography (pet) in adults with prostate cancer (pca) in the following clinical settings:primary staging of patients with high risk pca prior to primary curative therapy,suspected pca recurrence in patients with increasing levels of serum prostate specific antigen (psa) after primary curative therapy,identification of patients with psma positive progressive metastatic castration resistant prostate cancer (mcrpc) for whom psma targeted therapy is indicated (see section 4.

欧盟 - 爱沙尼亚文 - EMA (European Medicines Agency)

curium pet france - piflufolastat (18f) - eesnäärmevähk - diagnostilised radiofarmatseutilised ühendid - see ravim on mõeldud ainult diagnostiliseks kasutamiseks. pylclari is indicated for the detection of prostate-specific membrane antigen (psma) positive lesions with positron emission tomography (pet) in adults with prostate cancer (pca) in the following clinical settings:primary staging of patients with high-risk pca prior to initial curative therapy,to localize recurrence of pca in patients with a suspected recurrence based on increasing serum prostate-specific antigen (psa) levels after primary treatment with curative intent. pylclari is indicated for use with positron emission tomography (pet).

欧盟 - 爱沙尼亚文 - EMA (European Medicines Agency)

blue earth diagnostics ireland ltd - fluciclovine (18f) - prostatic neoplasms; radionuclide imaging - diagnostilised radiofarmatseutilised ühendid - see ravim on mõeldud ainult diagnostiliseks kasutamiseks. axumin on näidustatud positronemissioontomograafia (pet) pildindus avastada kordumise eesnäärmevähi täiskasvanud mehed, kellel kahtlustatakse kordumise põhineb vere kõrgenenud eesnäärmevähi spetsiifilise antigeeni (psa) taseme pärast esmast tervendavat ravi.

欧盟 - 爱沙尼亚文 - EMA (European Medicines Agency)

accord healthcare s.l.u. - degarelix acetate - eesnäärmevähk - other hormone antagonists and related agents - degarelix accord is a gonadotrophin releasing hormone (gnrh) antagonist indicated:for treatment of adult male patients with advanced hormone-dependent prostate cancer. for treatment of high-risk localised and locally advanced hormone dependent prostate cancer in combination with radiotherapy. as neo-adjuvant treatment prior to radiotherapy in patients with high-risk localised or locally advanced hormone dependent prostate cancer.

爱沙尼亚 - 爱沙尼亚文 - Ravimiamet

citomed mb npk zao - prostata ekstrakt - süstelahuse pulber - 5mg 5tk

爱沙尼亚 - 爱沙尼亚文 - Ravimiamet

lekhim-harkov - prostata ekstrakt - rektaalsuposiit - 30mg 5tk

爱沙尼亚 - 爱沙尼亚文 - Ravimiamet

biopharma llc - prostata ekstrakt - süstelahuse pulber - 10mg 10tk